Fda approves medtronic minimed™ 780g system - world's first insulin pump with meal detection technology* featuring 5-minute auto corrections†§

Available in europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the medtronic family of pumps dublin , april 21, 2023 /prnewswire/ --  medtronic plc (nyse: mdt), the global leader in medical technology, today announced u.s. food and drug administration (fda) approval of its minimed™ 780g system with the guardian™ 4 sensor requiring no fingersticks while in smartguard™ technology‡. this milestone marks the approval of the only system with meal detection technology* that provides automatic adjustments and corrections† to sugar levels every 5 minutes§ for both basal (background) and bolus (mealtime) insulin needs.
MDT Ratings Summary
MDT Quant Ranking